The Optical Remote Monitoring Blood Pressure Revolution ...at Your Fingertip.
We're on a mission to make democratized blood pressure management via instant, ubiquitous, and accurate remote monitoring a reality. With a touch of the finger, the Biospectal OptiBP™ platform allows anyone to transform mobile devices into a medical grade blood pressure monitoring solution wherever and whenever it's needed...
We're in the running for the #1 Swiss startup! Please vote for us and help us fight the global blood pressure epidemic and improve the lives of millions.
We are working relentlessly to democratize blood pressure management at global scale using breakthrough transdermal optical biosensing in mobile devices. It’s a privilege to be recognized for our vision, passion, and progress as one of the top three Swiss Medtech Award 2022 Finalists. The winner of the prestigious award and cash prize will be announced at Swiss Medtech Day on June 14 in Bern, Switzerland
For more on the Swiss Medtech 2022 Award and finalists, read here.
Biospectal chosen as an example of an Innovation project supported by Innosuisse
Innosuisse, the Swiss Innovation Agency, has featured Biospectal as a success story in fostering innovation through Swiss technology. The video profile highlights the unique opportunity Biospectal is pursuing in partnership with CSEM, the Swiss Center for Electronics and Microtechnology, to use software-only, cuffless blood pressure monitoring and management in smartphones to scale hypertension management globally. https://www.innosuisse.ch/inno/en/home/results-and-impact/funding-examples/innovation-projects/biospectal.html
Biospectal’s Innosuisse Project Featured as a Success Story in Innovation
Innosuisse, a key supporter of Biospectal’s research and development efforts, recently created a feature video to highlight the innovation we are pursuing in algorithm development to enable optical recording of blood pressure through the fingertip with a smartphone camera. We are grateful for their support and would not be where we are without it! The Video can be viewed here.
Biospectal Chosen as One of Three Top Swiss Healthcare Startups for SHS Healthcare Madness
We’re at it again! Come visit us in Lausanne, Switzerland on 16 May where Biospectal will present as one of three top innovators by Swiss Healthcare Startups. We’ll present to a select group at SHS Healthcare Madness with Antoine Hubert (Swiss Medical Network) and Nicolas Durand (Abionic) in attendance. For details, see: https://swisshealthcarestartups.com/en/events/shs-healthcare-madness
Biospectal Joins CSEM at Swissnex Boston and MIT to Discuss Digital Health Innovation
Biospectal joined a panel hosted by the Swiss Center for Electronics and Microtechnology (CSEM) on February 20th in Cambridge, Massachusetts to dialogue about Swiss and American perspectives on Digital Health Innovation. CSEM opened the evening by sharing their most recent innovations in health related technology, including a focus on health sensors and non-invasive approaches to biosensing. Eliott Jones from Biospectal continued to present their non-invasive optical algorithm technology that they’re
Biospectal Wins 2018 MassChallenge Gold Prize Among 1000 Competitors
We are honored to have Biospectal’s cuffless optical blood pressure solution recognized by being awarded MassChallenge Switzerland’s 2018 Gold prize from a field of 1000 applicants and many talented cohort participants. A shout out to our technology research partner, CSEM for their brilliance and support. Professor Patrick Schoettker, co-founder and chief medical advisor of Biospectal, received the award for the team. “We are passionate and driven to bring non-invasive technologies
Biospectal Selected as One of Ten Finalists for the “Saving Lives at Birth” 2018 Grand Challenge
Biospectal was recently selected from more than five hundred applicants to present with our partner team at the Saving Lives at Birth Global Grand Challenge DEVELOPMENTxCHANGE conference in Washington, D.C. Saving Lives at Birth is focused on identifying and scaling transformative prevention and treatment approaches for pregnant women and newborns. It brings together the U.S. Agency for International Development (USAID), the Government of Norway (Norad), the Bill and Melinda Gates Foundation, Grand